Clinical Significance of TP53, BIRC3, ATM and MAPK-ERK genes in Chronic Lymphocytic Leukaemia: Data from the Randomised UK LRF CLL4 Trial

Thumbnail Image

Files

46 Blakemore Leukemia 2019 accepted version.pdf (2.66 MB)

Embargo End Date

ICR Authors

Else, Monica

Authors

Else, M
Morilla, R
Catovsky, D

Document Type

Journal Article

Date

Date Accepted

2019-12-05

Abstract

Citation

Leukemia

DOI

URI

https://repository.icr.ac.uk/handle/internal/3476

Rights

https://www.rioxx.net/licenses/under-embargo-all-rights-reserved

Source Title

Publisher

ISSN

eISSN

Collections

Molecular Pathology

Research Team

Biology of Childhood Leukaemia

Notes